ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko05033	Nicotine addiction	7/120	56/7206	3.51611908965e-05
ko04974	Protein digestion and absorption	7/120	96/7206	0.00104411897963
ko04080	Neuroactive ligand-receptor interaction	16/120	423/7206	0.00230181723249
ko04810	Regulation of actin cytoskeleton	11/120	264/7206	0.00437894757005
ko04360	Axon guidance	10/120	233/7206	0.00532067906906
ko00534	Glycosaminoglycan biosynthesis - heparan sulfate / heparin	3/120	26/7206	0.00885597605932
ko05213	Endometrial cancer	4/120	62/7206	0.019433820536
ko05224	Breast cancer	7/120	174/7206	0.0257720504213
ko05217	Basal cell carcinoma	4/120	68/7206	0.0263073829644
ko04978	Mineral absorption	3/120	40/7206	0.0284547488858
ko05014	Amyotrophic lateral sclerosis (ALS)	4/120	74/7206	0.034474467319
ko04727	GABAergic synapse	5/120	110/7206	0.0361567309139
ko05032	Morphine addiction	5/120	110/7206	0.0361567309139
ko04724	Glutamatergic synapse	6/120	152/7206	0.0409330160926
ko04512	ECM-receptor interaction	4/120	79/7206	0.0422891177823
ko04911	Insulin secretion	5/120	117/7206	0.0452228802629